Login
Roast topics
Find topics
Find it!
From:
Sjogren's Disease News
(Uncensored)
subscribe
Safety, efficacy seen for Sjögren’s therapy ianalumab in pair of trials
https://sjogrenssyndromenews.com/news/safety-efficacy-seen-sjogrens-therapy-ianalumab-phase-3-trials/
links
backlinks
Tagged with:
news
clinical trials
disease activity
ianalumab
Roast topics
Find topics
Roast it!
Novartis' therapy candidate ianalumab safely and effectively eased disease activity for adults with active Sjögren's in two clinical trials.
